Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: INOPASE - Performance and Safety Study of a Personalised SNM System [NA]

View source ↗

Summary

Clinical trial update for INOPASE's personalised sacral neuromodulation system for overactive bladder; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Personalised Sacral Neuromodulation System (sacral neuromodulation system)

Snippet

Sponsor: INOPASE Pty Ltd | Conditions: Overactive Bladder (OAB) | NA | Status: RECRUITING